CAMP and myocardial infarction: To evaluate the clinical relevance of the human cathelicidin peptide LL-37 (human analogue of CRAMP), the serum levels of LL-37 were measured using ELISA in patients with myocardial infarction (MI, n = 172) compared to normal controls (n = 160).